Table 4.
Name | Description | Administration | Clinical Trials ID |
---|---|---|---|
NanoLithium® NP03 | Proof-of-concept study to assess safety, tolerance, and efficacy of NanoLithium® NP03 in patients with mild-to-severe AD | Depositing in the gingivo-jugal groove of each cheek | NCT05423522 |
APH-1105 | Study to assess the safety, tolerability, and efficacy of intranasal delivery of APH-1105 for the treatment of mild-to-moderate AD in adults | Intranasal | NCT03806478 |